Dermatologic drug development involves the creation and testing of new medications specifically designed to treat a wide range of skin conditions, from common issues like acne and eczema to more complex diseases such as psoriasis and skin cancer. The process of developing dermatologic drugs requires a thorough understanding of skin biology, as well as how drugs interact with the skin's layers and systems. Advances in dermatologic drug development have led to targeted therapies, such as biologics and topical immunomodulators, which offer more precise and effective treatments with fewer side effects compared to traditional options. In addition to systemic treatments, innovations in drug delivery systems, such as nanoparticles and liposomes, are improving the effectiveness and penetration of topical treatments. Dermatologic drug development also focuses on personalized medicine, tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. As research progresses, new therapies continue to emerge, offering better management and potential cures for a range of dermatological diseases.
Sergei A Grando
University of California Irvine, United States
Gustavo Hector Leibaschoff
World Society of Cosmetic Gynecology, United States
Nalini Kaul
Princeton Consumer Research, Canada
Dechelette Corinne
La Peau Autrement, France
Rachita Dhurat
LTMMC & LTMG Hospital, India
Frederick H Silver
Robert Wood Johnson Medical School, Rutgers University, United States
Daan Thorn Leeson
Rodan + Fields, United States
Brannon Claytor
Claytor Noone Plastic Surgery, United States
Shohreh Ghasemi
Oklahoma University, United States
Katie L Frederickson
Meharry Medical College, United StatesSubmit your abstract Today
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : The new physiopathology of cellulite
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : A twelve week clinical study testing efficacy and safety of a cosmetic cream with novel actives for uneven skin tone, hyperpigmentation & photoaging
Nalini Kaul, Princeton Consumer Research, Canada
Title : Bioregeneration in aesthetic and functional gynecology
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : Emerging frontiers in dermatologic regenerative medicine: Innovations in skin repair and rejuvenation
Shohreh Ghasemi, Oklahoma University, United States
Title : When the ozone layer fails to protect, ozone oil heals: A case report on the use of topical ozone therapy as an adjuvant in the treatment of complicated wounds
Alexandra Soares, USF Receber e Cuidar - ULS Castelo Branco, Portugal
Title : Learning from 15 years of multidisciplinary lupus clinic
Bairbre Wynne, St James Hospital, Ireland
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-Inspired translational & data-driven applications: An option for clinical dermatologists, skin care experts and consumers to realize the unique potential of getting personal about skin and skin conditions to secure the human biosafety?
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation